CorMedix (CRMD) Operating Leases (2019 - 2025)
CorMedix (CRMD) has disclosed Operating Leases for 7 consecutive years, with $2.3 million as the latest value for Q4 2025.
- Quarterly Operating Leases rose 545.56% to $2.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.3 million through Dec 2025, up 545.56% year-over-year, with the annual reading at $2.3 million for FY2025, 545.56% up from the prior year.
- Operating Leases hit $2.3 million in Q4 2025 for CorMedix, down from $2.4 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $2.4 million in Q3 2025 to a low of $304092.0 in Q1 2025.
- Historically, Operating Leases has averaged $818102.7 across 5 years, with a median of $702947.0 in 2022.
- Biggest five-year swings in Operating Leases: skyrocketed 47205.04% in 2021 and later tumbled 44.1% in 2024.
- Year by year, Operating Leases stood at $802433.0 in 2021, then dropped by 16.8% to $667632.0 in 2022, then grew by 5.3% to $703000.0 in 2023, then plummeted by 50.36% to $349000.0 in 2024, then surged by 545.56% to $2.3 million in 2025.
- Business Quant data shows Operating Leases for CRMD at $2.3 million in Q4 2025, $2.4 million in Q3 2025, and $435000.0 in Q2 2025.